» Articles » PMID: 7747724

Familial Predisposition to Nephropathy in African-Americans with Non-insulin-dependent Diabetes Mellitus

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 1995 May 1
PMID 7747724
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Nephropathy clusters in Pima Indian families with non-insulin-dependent diabetes mellitus (NIDDM), suggesting that susceptibility to nephropathy is distinct from NIDDM per se. The authors compared the family history of end-stage renal disease (ESRD) from 52 African-American patients with NIDDM-induced ESRD (cases) with 45 age-, sex-, and and race-matched non-insulin-dependent diabetics without nephropathy (controls) to assess whether the risk of renal disease was independent from NIDDM in African-Americans as well. Thirty-seven percent (19 of 52) of NIDDM-induced ESRD patients had either a first-, second-, or third-degree relative with ESRD, in contrast to only 7% (3 of 45) of diabetic controls. African-American individuals with NIDDM were at eightfold increased risk for developing subsequent ESRD in the presence of a close relative with ESRD (odds ratio = 8.06; 95% confidence interval, 2.2 to 29.6; P < or = 0.0005). No significant differences were observed in yearly income, years of formal education, total serum cholesterol level, prevalence of smoking, or hypertension between the groups. Diabetic control (assessed by glycosylated hemoglobin and random glucose levels) was suboptimal in nonrenal disease controls, suggesting that hyperglycemia alone fails to cause nephropathy in patients with NIDDM. Family size was unlikely to have influenced the results because diabetic cases had significantly fewer first-degree relatives than did diabetic controls. Familial clustering of ESRD is present in certain African-American families with NIDDM. Differences in family size and degree of diabetic control are unlikely to account for the differences observed between families.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Parallelism and non-parallelism in diabetic nephropathy and diabetic retinopathy.

Tang S, An X, Sun W, Zhang Y, Yang C, Kang X Front Endocrinol (Lausanne). 2024; 15:1336123.

PMID: 38419958 PMC: 10899692. DOI: 10.3389/fendo.2024.1336123.


The Minnesota attributable risk of kidney donation (MARKD) study: a retrospective cohort study of long-term (> 50 year) outcomes after kidney donation compared to well-matched healthy controls.

Vock D, Helgeson E, Mullan A, Issa N, Sanka S, Saiki A BMC Nephrol. 2023; 24(1):121.

PMID: 37127560 PMC: 10152793. DOI: 10.1186/s12882-023-03149-7.


Nidogen-1 could play a role in diabetic kidney disease development in type 2 diabetes: a genome-wide association meta-analysis.

Khattab A, Torkamani A Hum Genomics. 2022; 16(1):47.

PMID: 36271454 PMC: 9587571. DOI: 10.1186/s40246-022-00422-y.


The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies.

Tziastoudi M, Stefanidis I, Zintzaras E Clin Kidney J. 2020; 13(5):768-781.

PMID: 33123356 PMC: 7577775. DOI: 10.1093/ckj/sfaa077.


Epigenetic Regulation of Circadian Rhythm and Its Possible Role in Diabetes Mellitus.

Hudec M, Dankova P, Solc R, Bettazova N, Cerna M Int J Mol Sci. 2020; 21(8).

PMID: 32344535 PMC: 7215839. DOI: 10.3390/ijms21083005.